Market Tracker

09/23 6:02pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
7.19 +0.02 / +0.28%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.19 0.00 / 0.00%
 
Volume: 25.3K

Today’s Trading

Previous close7.17
Today’s open7.14
Day’s range7.07 - 7.38
Volume777,956
Average volume (3 months)1,308,855
Market cap$749.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+27.71%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.20-4.08%
ENTAEnanta Pharmaceutica...-0.14-0.36%
EBSEmergent BioSolution...-0.38-1.75%
NLNKNewLink Genetics Cor...+0.32+1.30%
Data as of 4:02pm ET, 09/23/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts